Clinical & Experimental Metastasis

Papers
(The TQCC of Clinical & Experimental Metastasis is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The value of case reports in rare oncological scenarios: mixed method analysis of colorectal metastases from breast cancer83
Congratulations to Prof. em. Garth L. Nicolson – co-founder of Clinical & Experimental Metastasis67
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer61
Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro‐intestinal peritoneal metastases in laboratory animals: a systematic review45
Stereotactic body radiation therapy for adrenal gland metastases: outcome and predictive factors from a multicenter analysis42
The gastrointestinal microbiota in colorectal cancer cell migration and invasion40
Cutting-edge innovations in breast cancer diagnosis- the potential of HDMI biomarkers33
Metastatic profiling of HER2-positive breast cancer cell lines in xenograft models33
Multiple myeloma: clinical characteristics, current therapies and emerging innovative treatments targeting ribosome biogenesis dynamics33
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy31
Efficacy and safety of thoracic radiotherapy for extensive stage small cell lung cancer after immunotherapy in real world30
The murine metastatic microenvironment of experimental brain metastases of breast cancer differs by host age in vivo: a proteomic study30
Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics29
Current status of gastrointestinal tract cancer brain metastasis and the use of blood-based cancer biomarker biopsy25
Cancer heterogeneity and metastasis: life at the edge22
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275)19
Donald L. Morton Memorial Lecture: the legacy of Donald Morton: past, present and future19
Detection of sentinel lymph nodes by tilmanocept in oral squamous cell carcinoma18
The effect of the low stromal ratio induced by neoadjuvant chemotherapy on recurrence patterns in borderline resectable pancreatic ductal adenocarcinoma18
A new Neu—a syngeneic model of spontaneously metastatic HER2-positive breast cancer16
The movement of mitochondria in breast cancer: internal motility and intercellular transfer of mitochondria15
Pulmonary lysyl oxidase expression and its role in seeding Lewis lung carcinoma cells15
Factors associated with the distribution of brain metastases in lung cancer: a retrospective study15
Personalized therapy in oncology: melanoma as a paradigm for molecular-targeted treatment approaches15
PIM3 kinase promotes tumor metastasis in hepatoblastoma by upregulating cell surface expression of chemokine receptor cxcr414
Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology14
Nanoparticles loaded with circ_0086375 for suppressing the tumorigenesis of pancreatic cancer by targeting the miR-646/SLC4A4 axis14
Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils14
Emerging photoacoustic and thermoacoustic imaging technologies for detecting primary and metastatic cancer and guiding therapy14
LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression14
Immunotherapy of cancer in the era of checkpoint inhibitor14
CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells13
Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis13
Poor patient outcome correlates with active engulfment of cytokeratin positive CTCs within cancer-associated monocyte population in lung cancer13
Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer13
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on 18F-FDG13
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer13
Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review12
Cancer neoantigens as potential targets for immunotherapy12
Secondary lymphedema from cancer therapy12
Occludin is overexpressed in tubo-ovarian high-grade serous carcinoma compared to mesothelioma and is a marker of tumor progression and chemoresistance11
EGFL6 promotes bone metastasis of lung adenocarcinoma by increasing cancer cell malignancy and bone resorption11
Detection of melanoma, breast cancer and head and neck squamous cell cancer sentinel lymph nodes by Tc-99m Tilmanocept (Lymphoseek®)11
Correction: Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma10
In-transit metastatic cutaneous melanoma: current management and future directions10
Molecular mechanisms of cancer metastasis via the lymphatic versus the blood vessels10
The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis10
Predictive value of 18 F-FDG PET/CT versus bone marrow biopsy and aspiration in pediatric neuroblastoma10
Stereotactic radiotherapy for liver oligometastases: a pooled analysis following the estro/eortc consensus recommendations10
Breast cancer disparities in outcomes; unmasking biological determinants associated with racial and genetic diversity9
Application of CTC discoveries for liquid biopsy: the RPL/RPS gene signature of melanoma CTCs is linked to brain metastasis onset9
Letter: Estimating the baseline local recurrence rate for a brain metastasis after neurosurgical resection8
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation8
Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis8
Should EUS-FNA be considered also for the diagnosis of peripheral small pulmonary lesions?8
Acetone compression improves lymph node yield and metastasis detection in colorectal cancer8
Preoperative embolization of renal cell carcinoma metastases to the bone prior to stabilization procedures does not result in reduction in intraoperative blood loss8
Dissecting the tumor microenvironment in response to immune checkpoint inhibitors via single-cell and spatial transcriptomics8
Clinical applications of circulating tumor cells in patients with solid tumors8
Oncolytic intralesional therapy for metastatic melanoma8
0.069934844970703